4wealth Advisors »

BioMarin Pharmaceutical shares owned by 4wealth Advisors

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by 4wealth Advisors from 13F filings

Historical chart of 4wealth Advisors investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by 4wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by 4wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $212k 3.6k 59.43

More positions owned by 4wealth Advisors

J P Morgan Exchange Traded F Equity Premium (JEPI)
Northern Lts Fd Tr Iv Monarch Procap I (MPRO)
NVIDIA Corporation (NVDA)
J P Morgan Exchange Traded F Nasdaq Eqt Prem (JEPQ)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Apple (AAPL)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Microsoft Corporation (MSFT)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Ishares Tr Us Treas Bd Etf (GOVT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Pgim Etf Tr Pgim Ultra Sh Bd (PULS)
Johnson & Johnson (JNJ)
Ishares Tr 0-3 Mnth Treasry (SGOV)

View all positions for 4wealth Advisors

Top funds holding BioMarin Pharmaceutical

BlackRock
Vanguard Group
Dodge & Cox
PRIMECAP Management Company
Norges Bank Investment Management
State Street Corporation
Viking Global Investors
AQR Capital Management
Geode Capital Management
Dimensional Fund Advisors
Vestal Point Capital
Millennium Management
Capital Research Global Investors
UBS Group
Deep Track Capital

View all funds holding BioMarin Pharmaceutical